Fig. 4
Histopathological tumor regression rates by clinicopathological characteristics. a MPR; b ypT0N0. MPR major pathological response, PD-L1 programmed cell death-ligand 1, CPS combined positive score
Fig. 4 | Signal Transduction and Targeted Therapy
